dr perlmutter parkinsons treatment glutathione Frontiers Perlmutter Receives $3.2M to Study
Perlmutter Receives $3.2M to Study Parkinson's Disease Brain Inflammation Mallinckrodt Institute of Radiology WashU Medicine Initial management of Parkinson's disease The BMJ Mechanism of Toxicity in Rotenone Models of Parkinson's Disease Journal of Neuroscience Potential use of glutathione as a treatment for Parkinson's disease PMC Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives ACS Omega Perlmutter named scientific director of dystonia foundation WashU Medicine
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12





